H.R. 6348 — Introduced in House

I 114th CONGRESS 2d Session H. R. 6348 IN THE HOUSE OF REPRESENTATIVES November 17, 2016Mr. Grayson introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To extend for two years the program for priority review to encourage treatments for rare pediatric diseases. 1. Extension of program for priority review to encourage treatments for rare pediatric diseases Section 529(b)(5) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360ff(b)(5)) is amended by striking December 31, 2016 and inserting December 31, 2018.